Quarterly Consolidated Statement Of Cash Flows

Cytori Cell Research Institute,Inc. - Filing #7297366

Concept As at
2024-09-30
2024-04-01 to
2024-09-30
As at
2024-03-31
As at
2023-09-30
2023-04-01 to
2023-09-30
As at
2023-03-31
Quarterly consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
-431,764,000 JPY
-419,281,000 JPY
Depreciation
26,600,000 JPY
104,837,000 JPY
Amortization of goodwill
JPY
22,966,000 JPY
Interest and dividend income
-220,000 JPY
-212,000 JPY
Interest expenses
37,467,000 JPY
79,310,000 JPY
Decrease (increase) in trade receivables
40,909,000 JPY
3,248,000 JPY
Decrease (increase) in inventories
-4,286,000 JPY
-56,618,000 JPY
Increase (decrease) in trade payables
-1,661,000 JPY
-114,000 JPY
Other, net
-50,521,000 JPY
2,484,000 JPY
Subtotal
-485,493,000 JPY
-287,489,000 JPY
Interest and dividends received
220,000 JPY
212,000 JPY
Interest paid
-37,807,000 JPY
-78,657,000 JPY
Net cash provided by (used in) operating activities
-420,752,000 JPY
-367,057,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-7,634,000 JPY
-3,511,000 JPY
Proceeds from sale of shares of subsidiaries resulting in change in scope of consolidation
3,249,000 JPY
JPY
Other, net
250,000 JPY
18,000 JPY
Net cash provided by (used in) investing activities
-4,134,000 JPY
-3,492,000 JPY
Cash flows from financing activities
Proceeds from short-term borrowings
JPY
100,000,000 JPY
Repayments of short-term borrowings
-70,000,000 JPY
JPY
Repayments of long-term borrowings
-26,815,000 JPY
-194,322,000 JPY
Purchase of shares of subsidiaries not resulting in change in scope of consolidation
-4,776,000 JPY
JPY
Other, net
JPY
-107,000 JPY
Net cash provided by (used in) financing activities
-101,591,000 JPY
-94,430,000 JPY
Net increase (decrease) in cash and cash equivalents
-526,479,000 JPY
-464,980,000 JPY
Cash and cash equivalents
521,986,000 JPY
1,038,227,000 JPY
208,070,000 JPY
673,050,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.